Carl Zeiss Meditec has completed the acquisition of ianTECH
Carl Zeiss Meditec has completed the acquisition of ianTECH, a privately held company focused on technology solutions for micro-interventional cataract surgery headquartered in
“Cataract surgery has been dependent on phaco technology for over 50 years. ZEISS believes that the market needs a fresh, innovative approach in the field of phaco. ianTECH’s surgical technology is designed to change the future of managing cataracts,” said a spokeswoman.